Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00918073 · ClinicalTrials.gov registry record
Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Patients
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 50
- Enrollment target
NCT00918073 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 50 participants.
The verdict
NCT00918073 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
We will conduct a sub-study of "An Innovative Telephone Intervention for HIV+ Smokers," (NCT00502827) conducted by Drs. Gritz, Vidrine, and others. This is a randomized, prospective trial that will evaluate a cellular phone delivered counseling intervention versus standard of care for smoking cessation. In our sub-study, we will evaluate rates of progression in atherosclerosis in HIV/AIDS patients who quit smoking versus those who continue smoking by measuring carotid intima-media thickness(CIMT) and biomarkers of atherosclerosis at time point baseline, 1 year, and 3 year. The biomarkers measured include high-sensitivity Creactive protein, homocysteine, and IL-6. We will also evaluate rates of progression of CIMT in those who quit smoking versus those who continue smoking, based on race, sex, state of HIV disease, comorbid diseases, and lipid profile.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-11 |
| Est. Completion | 2013-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00918073
The ClinicalTrials.gov registry entry for NCT00918073 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00918073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00918073 about?
NCT00918073 is a clinical study titled "Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Patients". We will conduct a sub-study of "An Innovative Telephone Intervention for HIV+ Smokers," (NCT00502827) conducted by Drs. Gritz, Vidrine, and others. This is a randomized, prospective trial that will evaluate a cellular phone delivered counseling intervention versus standard of care for smoking cessat...
What is the current status of trial NCT00918073?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2007-11. Estimated completion is 2013-04.
Who is sponsoring clinical trial NCT00918073?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.